North America Down Syndrome Market Analysis

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Pharmaceutical North America Down Syndrome Market Market Analysis
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Down Syndrome Market Analysis

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • North America
  • 350 Pages
  • No of Tables: 597
  • No of Figures: 46
Buy Now Buy Now

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of North America Down syndrome market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. treatment of Down syndrome LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET END USER COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. North America Down syndrome market : Pipeline analysis
    1. PIPELINE PRODUCTS IMPACT ANALYSIS
    2. NNI-351
    3. ASPARAGINASE
    4. ANVS-401
    5. QUILLIVANT XR
    6. TOFACITINIB
    7. MEMANTINE HYDROCHLORIDE
    8. NICOTINE
    9. AEF0217
    10. ACI-24
  5. North America Down syndrome market : Laws and regulations
  6. Market Overview
    1. Drivers
      1. increasing prevalence OF DOWN syndrome
      2. rising demand of effective therapies
      3. rising awareness about the diseasE
      4. technological ADVANCEMENTS
      5. increasing government support
    2. RESTRAINTS
      1. UNAVAILABILITY OF any specific treatment
      2. Side Effects Associated With Down Syndrome Treatment Therapies
      3. high cost of diagnosis
    3. opportunities
      1. STRATEGIC INITIATIVES BY MARKET PLAYERS
      2. increasing research and development
      3. presence of pipeline therapies
      4. presence of reimbursement
    4. challenGes
      1. Lack of Skilled Proffessionals
      2. Long Process for Product Launch
      3. Transfer of COVID-19 Infections by Diagnostic Methods
  7. Impact of COVID-19 on North America Down syndrome market
    1. Price Impact
    2. Impact on Supply Chain
    3. Impact on Demand
    4. Strategic Decisions for Manufacturers
    5. Conclusion
  8. North America down syndrome market, BY disease Type
    1. overview
    2. trisomy 21
    3. translocation Down syndrome
    4. mosaic Down syndrome
  9. North America down syndrome market, BY treatment
    1. overview
    2. diagnosis
      1. Screening Tests
        1. First Trimester
          1. Blood Test
          2. Nuchal Translucency Testing
        2. Integrated Screening Test
          1. First Trimester
          2. Second Trimester
        3. The Triple Screen or Quadraple Screen Test
        4. Ultrasound
        5. Cell Free DNA
      2. Diagnostic Tests
        1. Chronic Villus Sampling
        2. Amniocentesis
        3. Precutaneous Umbical Cord Sampling
    3. therapy
      1. Early Intervention Therapy
        1. Speech-Language Therapy
        2. Physical Therapy
        3. Occupational Therapy
        4. Others
      2. Assistive Technology
        1. Hearing Aids
        2. Glasses
        3. Others
      3. Surgery
        1. Atrioventricular Septal Defect (AVSD)
        2. Duodenal Atresia
        3. Others
      4. Others
  10. North America down syndrome market, BY end user
    1. overview
    2. hospital
    3. clinics
    4. homecare setting
    5. others
  11. North America down syndrome market, BY distribution channel
    1. overview
    2. direct tender
    3. retail sales
    4. others
  12. North America down syndrome market, by Country
    1. North America
      1. U.S.
      2. Canada
      3. Mexico
  13. North America Down syndrome market : COMPANY landscape
    1. company share analysis: north america
  14. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    2. PerkinElmer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. Illumina, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Myriad Genetics, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Abnova Corporation
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. AtilaBiosystems
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. Boston Children's Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Boys Town National Research Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. Children's Hospital Colorado
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Mayo Clinic Health System
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. Natera, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. Novus Biologicals (A Subsidiary of Bio-Techne)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
  15. questionnaire
  16. related reports

List of Table

TABLE 1 North America Down syndrome market : Pipeline Analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 North America down syndrome market, By Disease Type, 2019-2028 (USD million)

TABLE 4 North America down syndrome market, By Treatment, 2019-2028 (USD million)

TABLE 5 NORTH AMERICA Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 6 NORTH AMERICA screening tests in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 7 NORTH AMERICA First Trimester in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 8 NORTH AMERICA Integrated Screening Test in Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 9 NORTH AMERICA Diagnostic Tests in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 10 NORTH AMERICA Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 11 NORTH AMERICA Early Intervention Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 12 NORTH AMERICA Assistive Technology in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 13 NORTH AMERICA Surgery in Down Syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 14 NORTH AMERICA Down SYNDROME Market, By End User, 2019-2028 (USD million)

TABLE 15 North America down syndrome market, By Distribution Channel, 2019-2028 (USD million)

TABLE 16 North America down syndrome market, By Country, 2019-2028 (USD million)

TABLE 17 North America down syndrome market, By disease type, 2019-2028 (USD million)

TABLE 18 North America down syndrome market, By treatment, 2019-2028 (USD million)

TABLE 19 NORTH AMERICA diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD million)

TABLE 20 NORTH AMERICA screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 21 NORTH AMERICA first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 22 NORTH AMERICA integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 23 NORTH AMERICA diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 24 NORTH AMERICA therapy in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 25 NORTH AMERICA early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 26 NORTH AMERICA assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 27 NORTH AMERICA surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD million)

TABLE 28 North America down syndrome market, By End User, 2019-2028 (USD million)

TABLE 29 North America down syndrome market, By Distribution Channel, 2019-2028 (USD million)

TABLE 30 U.S. Down SYNDROME MARKET, By disease type, 2019-2028 (USD million)

TABLE 31 U.S. Down SYNDROME MARKET, By treatment, 2019-2028 (USD million)

TABLE 32 U.S. diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD million)

TABLE 33 U.S. screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 34 U.S. first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 35 U.S. integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 36 U.S. diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 37 U.S. therapy in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 38 U.S. early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 39 U.S. assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 40 U.S. surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD million)

TABLE 41 U.S. Down syndrome Market, By End User, 2019-2028 (USD million)

TABLE 42 U.S. Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD million)

TABLE 43 canada Down SYNDROME MARKET, By disease type, 2019-2028 (USD million)

TABLE 44 canada Down SYNDROME MARKET, By treatment, 2019-2028 (USD million)

TABLE 45 canada global diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD million)

TABLE 46 canada screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 47 canada first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 48 canada integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 49 canada diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 50 canada therapy in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 51 canada early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 52 canada assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 53 canada surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD million)

TABLE 54 canada Down syndrome Market, By End User, 2019-2028 (USD million)

TABLE 55 canada Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD million)

TABLE 56 mexico Down SYNDROME MARKET, By disease type, 2019-2028 (USD million)

TABLE 57 mexico Down SYNDROME MARKET, By treatment, 2019-2028 (USD million)

TABLE 58 mexico diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD million)

TABLE 59 mexico screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 60 mexico first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 61 mexico integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 62 mexico diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD million)

TABLE 63 mexico therapy in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 64 mexico early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 65 mexico assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD million)

TABLE 66 mexico surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD million)

TABLE 67 mexico Down syndrome Market, By End User, 2019-2028 (USD million)

TABLE 68 mexico Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD million)

List of Figure

FIGURE 1 North America Down syndrome market : SEGMENTATION

FIGURE 2 NORTH AMERICA DOWN SYNDROME MARKET : DATA TRIANGULATION

FIGURE 3 North America Down syndrome market : DROC ANALYSIS

FIGURE 4 North America Down syndrome MARKET: Regional VS. country MARKET ANALYSIS

FIGURE 5 North America Down syndrome market : COMPANY RESEARCH ANALYSIS

FIGURE 6 North America Down syndrome market : MULTIVARIATE MODELLING

FIGURE 7 North America Down syndrome market : INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA DOWN SYNDROME MARKET : DBMR MARKET POSITION GRID

FIGURE 9 North America Down syndrome market : MARKET END UsER COVERAGE GRID

FIGURE 10 NORTH AMERICA DOWN SYNDROME MARKET : VENDOR SHARE ANALYSIS

FIGURE 11 North America Down syndrome market : SEGMENTATION

FIGURE 12 Increasing PREVALENCE of Down syndrome and Other Related Disorders and Rising Demand for Effective therapies is DRIVing THE North America Down syndrome market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 trisomy 21 SEGMENT is expected to account for the largest share of the North America Down syndrome market in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF North America Down syndrome market

FIGURE 15 North America down syndrome market : BY disease type, 2020

FIGURE 16 North America down syndrome market : BY disease type, 2019-2028 (USD million)

FIGURE 17 North America down syndrome market : BY disease type, CAGR (2021-2028)

FIGURE 18 North America down syndrome market : BY disease type, LIFELINE CURVE

FIGURE 19 North America down syndrome market : BY treatment, 2020

FIGURE 20 North America Down syndrome MARKET: BY treatment, 2019-2028 (USD million).

FIGURE 21 North America down syndrome market : BY treatment, CAGR (2021-2028)

FIGURE 22 North America down syndrome market : BY treatment, LIFELINE CURVE

FIGURE 23 North America down syndrome market : BY end user, 2020

FIGURE 24 North America down syndrome market : BY end user, 2019-2028 (USD million)

FIGURE 25 North America down syndrome market : BY end user, CAGR (2021-2028)

FIGURE 26 North America down syndrome market : BY end user, LIFELINE CURVE

FIGURE 27 North America down syndrome market : BY distribution channel, 2020

FIGURE 28 North America down syndrome market : BY distribution channel, 2019-2028 (USD million)

FIGURE 29 North America down syndrome market : BY distribution channel, CAGR (2021-2028)

FIGURE 30 North America down syndrome market : BY distribution channel, LIFELINE CURVE

FIGURE 31 North America down syndrome market : SNAPSHOT (2020)

FIGURE 32 North America down syndrome market : BY COUNTRY (2020)

FIGURE 33 North America down syndrome market : BY COUNTRY (2021 & 2028)

FIGURE 34 North America down syndrome market : BY COUNTRY (2020 & 2028)

FIGURE 35 North America down syndrome market : BY Disease type (2021-2028)

FIGURE 36 North America Down syndrome MARKET: company share 2020 (%)

Browse Related Pages

Banner